Bioanalytical Systems Company Profile (NASDAQ:BASI)

About Bioanalytical Systems (NASDAQ:BASI)

Bioanalytical Systems logoBioanalytical systems, Inc. is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing.

Industry, Sector and Symbol:
  • Sector:
  • Industry: Research Services
  • Sub-Industry: N/A
  • Symbol: NASDAQ:BASI
  • CUSIP: N/A
  • Web: www.basinc.com
Capitalization:
  • Market Cap: $13.35 million
  • Outstanding Shares: 8,188,000
Average Prices:
  • 50 Day Moving Avg: $1.41
  • 200 Day Moving Avg: $1.11
  • 52 Week Range: $0.60 - $2.42
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 20.38
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $22.74 million
  • Price / Sales: 0.59
  • Book Value: $0.84 per share
  • Price / Book: 1.94
Profitability:
  • EBIDTA: $856,999.00
  • Net Margins: -15.80%
  • Return on Equity: -40.05%
  • Return on Assets: -14.44%
Debt:
  • Debt-to-Equity Ratio: 0.03%
  • Current Ratio: 0.36%
  • Quick Ratio: 0.25%
Misc:
  • Average Volume: 422,580 shs.
  • Beta: 0.73
  • Short Ratio: 0.04
 

Frequently Asked Questions for Bioanalytical Systems (NASDAQ:BASI)

What is Bioanalytical Systems' stock symbol?

Bioanalytical Systems trades on the NASDAQ under the ticker symbol "BASI."

How were Bioanalytical Systems' earnings last quarter?

Bioanalytical Systems, Inc. (NASDAQ:BASI) posted its earnings results on Monday, May, 15th. The company reported $0.05 earnings per share (EPS) for the quarter. The company earned $6.36 million during the quarter. Bioanalytical Systems had a negative net margin of 15.80% and a negative return on equity of 40.05%. View Bioanalytical Systems' Earnings History.

Who are some of Bioanalytical Systems' key competitors?

Who are Bioanalytical Systems' key executives?

Bioanalytical Systems' management team includes the folowing people:

  • Jill Blumhoff, Chief Financial Officer, Vice President - Finance
  • James S. Bourdage Ph.D., Vice President - Bioanalytical Operations
  • Philip A. Downing, Vice President - Preclinical Services
  • Connie Dougherty, Vice President - Business Development
  • Larry S. Boulet, Independent Director
  • Richard Allen Johnson Ph.D., Independent Director
  • Wendy Perrow, Independent Director

How do I buy Bioanalytical Systems stock?

Shares of Bioanalytical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bioanalytical Systems' stock price today?

One share of Bioanalytical Systems stock can currently be purchased for approximately $1.63.


MarketBeat Community Rating for Bioanalytical Systems (NASDAQ BASI)
Community Ranking:  1.4 out of 5 ()
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  15 (Vote Underperform)
Total Votes:  21
MarketBeat's community ratings are surveys of what our community members think about Bioanalytical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Bioanalytical Systems (NASDAQ:BASI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Bioanalytical Systems (NASDAQ:BASI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Bioanalytical Systems (NASDAQ:BASI)
Earnings by Quarter for Bioanalytical Systems (NASDAQ:BASI)
Earnings History by Quarter for Bioanalytical Systems (NASDAQ BASI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/15/2017Q2 2017$0.05$6.36 millionViewN/AView Earnings Details
8/11/2016Q316($0.05)$6.15 million$5.05 millionViewListenView Earnings Details
5/12/2016Q216($0.03)$5.73 million$5.34 millionViewListenView Earnings Details
2/16/2016Q116($0.06)$5.95 million$4.90 millionViewListenView Earnings Details
12/17/2015Q415($0.09)$6.42 million$4.98 millionViewListenView Earnings Details
8/13/2015Q315$0.16$6.03 million$6.15 millionViewListenView Earnings Details
5/14/2015Q215($0.01)$5.92 million$5.73 millionViewListenView Earnings Details
2/12/2015Q115$0.01$6.22 million$5.85 millionViewN/AView Earnings Details
12/22/2014Q414($0.02)$6.42 millionViewN/AView Earnings Details
8/14/2014Q314$0.02$5.60 million$6.03 millionViewN/AView Earnings Details
5/15/2014Q2($0.03)$5.16 million$5.91 millionViewListenView Earnings Details
2/13/2014Q114$0.04$5.80 million$6.22 millionViewN/AView Earnings Details
12/24/2013Q4 13$0.03$6.54 million$5.51 millionViewN/AView Earnings Details
10/18/2013Q313$0.01$0.07$5.65 million$5.60 millionViewN/AView Earnings Details
5/15/2013Q2 2013$0.01($0.02)$5.74 million$5.16 millionViewListenView Earnings Details
2/14/2013Q1 2013($0.03)$0.02$6.65 million$5.80 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bioanalytical Systems (NASDAQ:BASI)
Current Year EPS Consensus Estimate: $0.01 EPS
Next Year EPS Consensus Estimate: $0.08 EPS

Dividends

Dividend History for Bioanalytical Systems (NASDAQ:BASI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Bioanalytical Systems (NASDAQ:BASI)
Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 2.94%
Insider Trades by Quarter for Bioanalytical Systems (NASDAQ:BASI)
Insider Trades by Quarter for Bioanalytical Systems (NASDAQ:BASI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/27/2016Connie Leigh DoughertyVPBuy423$0.92$389.16View SEC Filing  
5/23/2016Connie Leigh DoughertyVPBuy96$0.92$88.32View SEC Filing  
5/19/2016Connie Leigh DoughertyVPBuy1,655$0.92$1,522.60View SEC Filing  
2/29/2016Jacqueline M LemkeCEOBuy10,000$1.18$11,800.00View SEC Filing  
9/14/2015Philip A DowningVPBuy3,000$1.73$5,190.00View SEC Filing  
2/27/2015Jacqueline M LemkeCEOBuy10,000$2.04$20,400.00View SEC Filing  
6/13/2014John P DevineVPSell3,130$2.64$8,263.20View SEC Filing  
8/17/2012David L OmachinskiDirectorBuy10,000$1.26$12,600.00View SEC Filing  
8/17/2012Jacqueline M LemkeCEOBuy20,000$1.26$25,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Bioanalytical Systems (NASDAQ:BASI)
Latest Headlines for Bioanalytical Systems (NASDAQ:BASI)
Source:
DateHeadline
finance.yahoo.com logoBioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q2, 2017 By the Numbers : May 24, 2017
finance.yahoo.com - May 24 at 11:00 AM
reuters.com logoBRIEF-BASI reports Q2 earnings per share $0.05
www.reuters.com - May 17 at 12:06 PM
americanbankingnews.com logoBioanalytical Systems, Inc. (BASI) Posts Earnings Results
www.americanbankingnews.com - May 16 at 3:48 PM
finance.yahoo.com logoBioanalytical Systems to Release Second Quarter Fiscal 2017 Results on Monday, May 15, 2017
finance.yahoo.com - May 10 at 4:02 PM
finance.yahoo.com logoBASi Announces Appointment of Scientific Advisor
finance.yahoo.com - May 1 at 3:48 PM
finance.yahoo.com logoBASi Names Philip A. Downing Senior Vice President of Preclinical Services
finance.yahoo.com - March 8 at 4:30 PM
finance.yahoo.com logoBASi Names Philip A. Downing Senior Vice President of Preclinical Services
finance.yahoo.com - March 8 at 4:30 PM
biz.yahoo.com logoQ1 2017 Bioanalytical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - February 14 at 8:27 PM
us.rd.yahoo.com logoBASi Reports First Quarter Results
us.rd.yahoo.com - February 14 at 8:27 PM
finance.yahoo.com logoBioanalytical Systems to Release First Quarter Fiscal 2017 Results on Tuesday, February 14, 2017
finance.yahoo.com - February 13 at 4:19 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
biz.yahoo.com - January 17 at 4:32 PM
finance.yahoo.com logoBIOANALYTICAL SYSTEMS INC Financials
finance.yahoo.com - January 4 at 3:56 PM
biz.yahoo.com logoQ4 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - December 22 at 3:51 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
biz.yahoo.com - December 22 at 3:51 PM
biz.yahoo.com logoBioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET today
biz.yahoo.com - December 22 at 3:51 PM
biz.yahoo.com logoBioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET today
biz.yahoo.com - December 22 at 3:51 PM
finance.yahoo.com logoCORRECTING and REPLACING Bioanalytical Systems to Release Fiscal 2016 Results on Thursday, December 22, 2016
finance.yahoo.com - December 20 at 4:07 PM
finance.yahoo.com logoBASi Names Alan Loch Director of Business Development
finance.yahoo.com - December 20 at 4:07 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
biz.yahoo.com - December 7 at 4:26 PM
finance.yahoo.com logoBioanalytical (BASI) Launches Sampling System, Stock Down
finance.yahoo.com - August 26 at 3:41 PM
finance.yahoo.com logoBASi Launches Embrace Automation Grant Program with Culex NxT™ Automated Blood Sampling System
finance.yahoo.com - August 25 at 8:35 AM
reuters.com logoBRIEF-Basi Q3 loss per share $0.05
www.reuters.com - August 12 at 12:20 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure
biz.yahoo.com - August 4 at 3:50 PM
finance.yahoo.com logoBioanalytical Systems to Release Third Quarter Fiscal 2016 Results on Thursday, August 11, 2016; Conference Call & Webcast Set For 11:00 am EDT
finance.yahoo.com - August 3 at 12:21 PM
finance.yahoo.com logoBASi Expands Electrochemical Offerings by Partnering with PalmSens BV
finance.yahoo.com - July 27 at 8:30 AM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
biz.yahoo.com - July 22 at 3:12 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - July 6 at 1:19 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - July 6 at 1:19 PM
finance.yahoo.com logoEdited Transcript of BASI earnings conference call or presentation 12-May-16 3:00pm GMT
finance.yahoo.com - May 18 at 6:53 AM
finance.yahoo.com logoBASi Reports Second Quarter Results
finance.yahoo.com - May 12 at 9:56 AM
biz.yahoo.com logoQ2 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open
biz.yahoo.com - May 12 at 7:07 AM
finance.yahoo.com logoBioanalytical Systems, Inc. Announces Appointment of New Chief Financial Officer
finance.yahoo.com - May 11 at 11:01 AM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
biz.yahoo.com - May 4 at 1:16 PM
finance.yahoo.com logoBASi Launches New Website and E-Catalogue
finance.yahoo.com - April 14 at 2:10 PM
finance.yahoo.com logoCORRECTING and REPLACING BASi Introduces the Next Generation of Electrochemical Analyzer With the Release of the Epsilon EClipse™
finance.yahoo.com - March 29 at 1:08 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - March 16 at 3:52 PM

Social

Chart

Bioanalytical Systems (BASI) Chart for Tuesday, May, 30, 2017

This page was last updated on 5/30/2017 by MarketBeat.com Staff